
CS Medica Investor Relations Material
Latest events

Q2 2024
CS Medica

Q4 2024
30 Nov, 2024

Q3 2024
16 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CS Medica
Access all reports
CS MEDICA is a Danish MedTech company that specializes in the research, development, manufacturing, and commercialization of medical products incorporating cannabinoids derived from the cannabis plant. The company focuses on creating innovative treatment solutions and skincare products utilizing natural Cannabidiol (CBD) to offer efficient and safe treatments for autoimmune and stress-related disorders. CS MEDICA's approach combines science and nature to provide products aimed at improving everyday life for its customers. The company's medical collection includes over-the-counter (OTC) CBD medical products and cosmetics. The company is headquartered in Copenhagen, Denmark, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CSMED
Country
🇩🇰 Denmark